SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021183
Filing Date
2018-08-10
Accepted
2018-08-10 06:06:03
Documents
65
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20180630.htm 10-Q 1427933
2 EX-10.6 elox-ex106_216.htm EX-10.6 98706
3 EX-31.1 elox-ex311_9.htm EX-31.1 8797
4 EX-31.2 elox-ex312_8.htm EX-31.2 9064
5 EX-32.1 elox-ex321_7.htm EX-32.1 6843
6 EX-32.2 elox-ex322_6.htm EX-32.2 6680
  Complete submission text file 0001564590-18-021183.txt   5563793

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT elox-20180630.xml EX-101.INS 1194178
8 XBRL TAXONOMY EXTENSION SCHEMA elox-20180630.xsd EX-101.SCH 45238
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20180630_cal.xml EX-101.CAL 29635
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20180630_def.xml EX-101.DEF 147003
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20180630_lab.xml EX-101.LAB 312946
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20180630_pre.xml EX-101.PRE 260433
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 181006932
SIC: 8731 Services-Commercial Physical & Biological Research
Assistant Director 9